Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Klotho Neurosciences Inc (KLTO)

Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,289
  • Shares Outstanding, K 72,537
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,150 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 10.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.69
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.32
  • Most Recent Earnings $-0.05 on 11/13/25
  • Next Earnings Date 03/30/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3655 +4.87%
on 12/16/25
0.5200 -26.29%
on 12/05/25
-0.0812 (-17.48%)
since 11/17/25
3-Month
0.3655 +4.87%
on 12/16/25
0.7200 -46.76%
on 10/16/25
-0.1867 (-32.75%)
since 09/17/25
52-Week
0.1135 +237.71%
on 04/04/25
3.9099 -90.20%
on 06/10/25
-0.0867 (-18.45%)
since 12/17/24

Most Recent Stories

More News
Beyond Weight Loss: The "Cellular Reset" That Could Create the Next Biotech Supercycle

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The longevity economy is entering a massive repricing event as researchers confirm that metabolic dysfunction...

LGVN : 0.6196 (+12.08%)
AVAI : 0.3172 (-0.16%)
BIOA : 12.81 (+2.40%)
GAA : 32.39 (-0.28%)
DNLI : 17.02 (+0.94%)
MAPT : 0.0003 (unch)
KLTO : 0.3811 (-2.28%)
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ) (the "Company" or "Klotho"), a U.S.-based biogenetics company, announces it has been selected as winner of the Fifth...

KLTO : 0.3811 (-2.28%)
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston

NEW YORK , Oct. 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") a U.S.-based biogenetics company, announces that members of its leadership team will...

KLTO : 0.3811 (-2.28%)
Klotho Neurosciences Announces Expiration of Letter of Intent

NEW YORK , Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") today announced that its Letter of Intent with Turn Biotechnologies was allowed to expire...

KLTO : 0.3811 (-2.28%)
Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

NEW YORK and PALO ALTO, Calif. , Sept. 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho" or "the Company") today announced it has signed a Letter of...

KLTO : 0.3811 (-2.28%)
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based therapeutics for neurodegenerative...

KLTO : 0.3811 (-2.28%)
Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

Key partnerships, regulatory  progress, manufacturing advancements, along with significant capital infusion accelerate the development of Klotho-based therapeutics

KLTO : 0.3811 (-2.28%)
Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology

NEW YORK , Aug. 12, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc . (Nasdaq: KLTO ), announces that it signed a binding agreement to initiate manufacturing and development of...

KLTO : 0.3811 (-2.28%)
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Company to Pursue Technologies to Improve Brain Function, Muscle Strength, Bone Health, and Other Longevity Indicators

KLTO : 0.3811 (-2.28%)
Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Company to Pursue Technologies to Improve Muscle Strength, Bone Health, and Other Longevity Indicators

KLTO : 0.3811 (-2.28%)

Business Summary

Klotho Neurosciences Inc. is a pharmaceutical company. It specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system which are seen as key developments in treating neurodegenerative and age-related disorders. Klotho Neurosciences Inc.,...

See More

Key Turning Points

3rd Resistance Point 0.4370
2nd Resistance Point 0.4178
1st Resistance Point 0.4039
Last Price 0.3811
1st Support Level 0.3708
2nd Support Level 0.3516
3rd Support Level 0.3377

See More

52-Week High 3.9099
Fibonacci 61.8% 2.4597
Fibonacci 50% 2.0117
Fibonacci 38.2% 1.5637
Last Price 0.3811
52-Week Low 0.1135

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar